Biogen sells factory
Posted: Sat Jun 18, 2005 12:20 am
In today's Times (UK) the following appeared in the business pages:
'Biogen Idec, the US biotech company, sold a new factory to Genentech, a US rival for $408 million (£223 million). It was built to make Tysabri, the multiple sclerosis drug withdrawn amid brain disease fears'.
Perhaps this indicates that Biogen is not confident of the drug returning in the near future.
Bromley
'Biogen Idec, the US biotech company, sold a new factory to Genentech, a US rival for $408 million (£223 million). It was built to make Tysabri, the multiple sclerosis drug withdrawn amid brain disease fears'.
Perhaps this indicates that Biogen is not confident of the drug returning in the near future.
Bromley